Ornithine and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ornithine (ornithine) and Ranitidine (ranitidine). Common drug interactions include sepsis among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Ornithine and Ranitidine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Ornithine?

Ornithine has active ingredients of ornithine. eHealthMe is studying from 591 Ornithine users. Check the latest studies of Ornithine.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

21 people who take Ornithine and Ranitidine together, and have interactions are studied.

Ornithine and Ranitidine drug interactions.

What are the common drug interactions of Ornithine and Ranitidine, by gender? *:

female:

Sepsis (a severe blood infection that can lead to organ failure and death)
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Angiopathy (generic term for a disease of the blood vessels)
Cholecystitis acute (rapid infection of gallbladder)
Lymphocyte count decreased
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pulmonary infarction (death of a small area of lung)
Pyrexia (fever)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)

male:

Abdominal pain
Aspartate aminotransferase increased
Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)
Dehydration (dryness resulting from the removal of water)
General physical health deterioration (weak health status)

What are the common drug interactions of Ornithine and Ranitidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Sepsis (a severe blood infection that can lead to organ failure and death)
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Lymphocyte count decreased

40-49:

Abdominal pain
Aspartate aminotransferase increased
Hypokalaemia (low potassium)
Liver carcinoma ruptured (ruptured liver cancer tumour)

50-59:

Pyrexia (fever)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Neutropenia (an abnormally low number of neutrophils)
Cardiac failure
Febrile neutropenia (fever with reduced white blood cells)
Nausea (feeling of having an urge to vomit)
Angiopathy (generic term for a disease of the blood vessels)
Cholecystitis acute (rapid infection of gallbladder)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pulmonary infarction (death of a small area of lung)

60+:

Dehydration (dryness resulting from the removal of water)
General physical health deterioration (weak health status)

What are the existing conditions these people have? *

High Blood Pressure: 8 people, 38.10%
Febrile Neutropenia (fever with reduced white blood cells): 8 people, 38.10%
Hepatic Neoplasm Malignant (liver cancer): 5 people, 23.81%
Liver Disorder (liver diseases): 5 people, 23.81%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 3 people, 14.29%
Hepatitis B: 3 people, 14.29%
Headache (pain in head): 3 people, 14.29%
Gallstones (stone formation by bile component): 3 people, 14.29%
Flatulence (flatus expelled through the anus): 3 people, 14.29%
Weakness: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Ornithine and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously